Al-Jefri A - Search Results

1

Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.

Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Jefri A, Al-Ahmari A, Ayas M, El-Solh H. Al-Mousa H, et al. Biol Blood Marrow Transplant. 2010 Jun;16(6):818-23. doi: 10.1016/j.bbmt.2010.01.002. Epub 2010 Jan 14. Biol Blood Marrow Transplant. 2010. PMID: 20079864 Free article.

2

Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence?

Ayas M, Al-Mahr M, Al-Jefri A, Rifai S, Solh H. Ayas M, et al. Bone Marrow Transplant. 2003 Feb;31(4):311; author reply 313. doi: 10.1038/sj.bmt.1703804. Bone Marrow Transplant. 2003. PMID: 12621470 No abstract available.

3

Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.

Belgaumi AF, Al-Bakrah M, Al-Mahr M, Al-Jefri A, Al-Musa A, Saleh M, Salim MF, Osman M, Osman L, El-Solh H. Belgaumi AF, et al. Cancer. 2003 Jun 1;97(11):2898-903. doi: 10.1002/cncr.11390. Cancer. 2003. PMID: 12767105 Free article.

4

The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen.

Ayas M, Al-Seraihi A, Al-Mahr M, Al-Jefri A, Belgaumi A, Elhassan I, El-Solh H. Ayas M, et al. Pediatr Blood Cancer. 2006 Dec;47(7):926-30. doi: 10.1002/pbc.20758. Pediatr Blood Cancer. 2006. PMID: 16425264

5

In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?

Ayas M, Al-Jefri A, Al-Seraihi A. Ayas M, et al. Pediatr Blood Cancer. 2008 Feb;50(2):426; author reply 427. doi: 10.1002/pbc.21211. Pediatr Blood Cancer. 2008. PMID: 17427233 No abstract available.

6

Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning.

Ayas M, Al-Jefri A, Al-Seraihi A, Al-Mahr M, Al-Ahmari A, El-Solh H. Ayas M, et al. Biol Blood Marrow Transplant. 2008 Apr;14(4):445-8. doi: 10.1016/j.bbmt.2008.02.004. Biol Blood Marrow Transplant. 2008. PMID: 18342787 Free article.

7

Outcome of second allogenic stem cell transplantation in pediatric patients with non-malignant hematological and immune deficiency disorders.

Ayas M, Al-Jefri A, Eldali A, Al-Seraihi A, Al-Mahr M, Al-Ghonaium A, Al-Ahmari A, Al-Muhsen S, Al-Mousa H, Al-Dhekri H, Al-Saud B, El-Solh H. Ayas M, et al. Pediatr Blood Cancer. 2011 Feb;56(2):289-93. doi: 10.1002/pbc.22804. Epub 2010 Oct 22. Pediatr Blood Cancer. 2011. PMID: 21157896

8

Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience.

Al-Dhekri H, Al-Mousa H, Ayas M, Al-Muhsen S, Al-Ghonaium A, Al-Ghanam G, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Ahmari A, Al-Jefri A, Al-Mahr M, El-Solh H. Al-Dhekri H, et al. Biol Blood Marrow Transplant. 2011 Aug;17(8):1245-9. doi: 10.1016/j.bbmt.2010.12.714. Epub 2011 Jan 8. Biol Blood Marrow Transplant. 2011. PMID: 21220036 Free article.

9

Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.

Al-Hajjar S, Al Seraihi A, Al Muhsen S, Ayas M, Al Jumaah S, Al Jefri A, Shoukri M, El Solh H. Al-Hajjar S, et al. Hematol Oncol Stem Cell Ther. 2011;4(2):67-72. doi: 10.5144/1658-3876.2011.67. Hematol Oncol Stem Cell Ther. 2011. PMID: 21727767 Free article.

10

Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.

Mohamed SY, Fadhil I, Hamladji RM, Hamidieh AA, Fahmy O, Ladeb S, Alimoghaddam K, Elhaddad A, Nacer RA, Alsharif F, Rasheed W, Jahani M, Mousavi SA, Alseraihy A, Abdel-Rahman F, Al Jefri A, Hussein AA, Alabdulaaly A, Ibrahim A, Bekadja MA, Abboud M, Ahmed P, Dennison D, Bakr M, Benchekroun S, Hussain F, Othman TB, Aljurf M, Ghavamzadeh A. Mohamed SY, et al. Hematol Oncol Stem Cell Ther. 2011;4(2):81-93. doi: 10.5144/1658-3876.2011.81. Hematol Oncol Stem Cell Ther. 2011. PMID: 21727769 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters